| Dr Mark D Wendt, DO | |
|
629 S Plummer Ave, Chanute, KS 66720-1928 | |
| (620) 431-4000 | |
| (620) 431-7556 |
| Full Name | Dr Mark D Wendt |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 629 S Plummer Ave, Chanute, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396832242 | NPI | - | NPPES |
| 2456456301 | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0526245 (Kansas) | Primary |
| Entity Name | Neosho Memorial Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023251469 PECOS PAC ID: 9133022882 Enrollment ID: O20040129000863 |
News Archive
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.
The part of the brain that helps control emotion may be larger in people who develop post-traumatic stress disorder (PTSD) after brain injury compared to those with a brain injury without PTSD, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.
Scientists at the Roskamp Institute, a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder.
Omega Healthcare Investors, Inc. today announced its results of operations for the three- and nine-month period ended September 30, 2011.
› Verified 1 days ago
| Entity Name | Neosho Memorial Regional Medical Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1073566949 PECOS PAC ID: 9133022882 Enrollment ID: O20061104000505 |
News Archive
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.
The part of the brain that helps control emotion may be larger in people who develop post-traumatic stress disorder (PTSD) after brain injury compared to those with a brain injury without PTSD, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.
Scientists at the Roskamp Institute, a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder.
Omega Healthcare Investors, Inc. today announced its results of operations for the three- and nine-month period ended September 30, 2011.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark D Wendt, DO 401 S Highland Ave, Chanute, KS 66720-2409 Ph: (620) 431-1938 | Dr Mark D Wendt, DO 629 S Plummer Ave, Chanute, KS 66720-1928 Ph: (620) 431-4000 |
News Archive
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.
The part of the brain that helps control emotion may be larger in people who develop post-traumatic stress disorder (PTSD) after brain injury compared to those with a brain injury without PTSD, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.
Scientists at the Roskamp Institute, a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder.
Omega Healthcare Investors, Inc. today announced its results of operations for the three- and nine-month period ended September 30, 2011.
› Verified 1 days ago
Martin Wayne Dillow, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 S Plummer Ave, Chanute, KS 66720 Phone: 620-431-2500 Fax: 620-431-4418 | |
Brian W Kueser, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 629 S Plummer Ave, Chanute, KS 66720 Phone: 620-431-4000 Fax: 620-431-7556 | |
Dr. Rebecca Lynn Watson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 629 S Plummer Ave, Chanute, KS 66720 Phone: 620-431-4000 | |
Verdon W Parham, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 W 7th St, Chanute, KS 66720 Phone: 620-432-5588 Fax: 620-431-1192 | |
Dr. Garrett Barton, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1501 W 7th St, Chanute, KS 66720 Phone: 620-432-5200 Fax: 620-431-1192 | |
David M Guernsey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 S Plummer Ave, Chanute, KS 66720 Phone: 620-431-2500 Fax: 620-431-4418 |